ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,223Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 3593

$764K Total Retail Price of All Prescriptions

Rank: 247 out of 3593

1,169 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 1,169 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 28,450 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$26 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,888 1,855 1 1
LISINOPRIL 1,843 1,785 2 2
LOVASTATIN 1,381 1,369 3 20
AMLODIPINE BESYLATE 1,368 1,363 4 3
HYDROCHLOROTHIAZIDE 1,242 1,222 5 10
METFORMIN HCL 1,163 1,155 6 6
LEVOTHYROXINE SODIUM 1,129 1,110 7 4
OMEPRAZOLE 1,094 1,075 8 5
METOPROLOL TARTRATE 790 781 9 8
ATENOLOL 659 644 10 11
LOSARTAN POTASSIUM 558 550 11 14
FUROSEMIDE 471 471 12 9
WARFARIN SODIUM 415 400 13 18
ALPRAZOLAM 412 407 14 37
ALENDRONATE SODIUM 399 399 15 22
DOXAZOSIN MESYLATE 396 396 16 63
GLIPIZIDE 358 334 17 40
RANITIDINE HCL 346 341 18 27
GABAPENTIN 339 331 19 16
ATORVASTATIN CALCIUM 305 284 20 15
MELOXICAM 301 275 21 29
SERTRALINE HCL 291 264 22 28
FINASTERIDE 285 285 23 79
CLOPIDOGREL 267 264 24 30
DONEPEZIL HCL 261 261 25 31
CLONIDINE HCL 259 253 26 41
ZOLPIDEM TARTRATE 252 252 27 12
HYDROCODONE-ACETAMINOPHEN 248 238 S3 28 7
TEMAZEPAM 239 239 29 56
PLAVIX 237 230 30 42
METOPROLOL SUCCINATE 225 209 31 19
FLUOXETINE HCL 224 208 32 60
PRAVASTATIN SODIUM 205 188 33 13
CARVEDILOL 202 198 34 23
DIGOXIN 195 178 35 58
GLYBURIDE 194 194 R 36 55
VIAGRA 190 190 37 84
VERAPAMIL ER 189 189 38 99
PAROXETINE HCL 189 189 38 62
TRIAMTERENE-HCTZ 187 182 40 66
ISOSORBIDE MONONITRATE ER 178 178 41 61
TAMSULOSIN HCL 169 162 42 33
ALLOPURINOL 143 143 43 35
NAPROXEN 140 139 44 68
DIOVAN 138 138 45 46
POTASSIUM CHLORIDE 133 133 46 24
CLOTRIMAZOLE-BETAMETHASONE 127 125 47 94
PREDNISONE 126 123 48 49
CRESTOR 124 116 49 21
AZITHROMYCIN 121 117 50 34
GEMFIBROZIL 116 116 51 88
CITALOPRAM HBR 109 109 52 25
FENOFIBRATE 105 93 53 39
TERAZOSIN HCL 101 101 54 115
FLUTICASONE PROPIONATE 99 81 55 32
JANTOVEN 98 98 56 169
GLIPIZIDE ER 97 97 57 101
SYNTHROID 94 94 58 51
EVISTA 94 94 58 200
NIFEDIPINE ER 93 82 60 75
ENALAPRIL MALEATE 88 82 61 38
INSULIN SYRINGE 88 83 61 91
CIPROFLOXACIN HCL 84 82 63 52
OXYBUTYNIN CHLORIDE 80 80 64 104
ADVAIR DISKUS 79 75 65 47
MECLIZINE HCL 77 77 66 96
LORAZEPAM 76 72 67 98
SPIRONOLACTONE 75 72 68 86
METHYLPREDNISOLONE 71 68 69 103
AMITRIPTYLINE HCL 71 71 R 69 90
CARTIA XT 70 70 71 299
BENAZEPRIL HCL 69 60 72 69
PROAIR HFA 68 68 73 54
FELODIPINE ER 68 68 73 229
KLOR-CON M20 67 67 75 139
HUMULIN 70-30 65 59 76 215
TRAZODONE HCL 61 49 77 53
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 61 77 26
ESTRADIOL 61 57 R 77 174
CILOSTAZOL 60 60 80 163
BUSPIRONE HCL 57 49 81 156
TRAMADOL HCL 57 57 81 17
LANTUS 56 49 83 57
DILTIAZEM 24HR CD 54 43 84 173
LATANOPROST 53 53 85 195
RAMIPRIL 51 48 86 92
NADOLOL 51 41 86 381
PENTOXIFYLLINE 51 51 86 149
KLOR-CON 10 50 50 89 114
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.